Strategic Portfolio Management Analyst
Danaher Corporation
Summary
The Strategic Portfolio Management Analyst is responsible for Molecular Devices' yearly strategy process, strategic portfolio management and execution of cross-business strategic initiatives. The role combines structured analysis, cross-functional coordination and Daily Management to translate strategic priorities into clear initiatives, measurable actions and sustained execution. This position reports to the Director of Product Management and is part of the Product Management organization, working closely with Finance, R&D, Commercial, Scientific Applications, and Marketing, located in San Jose, CA, and will be an on-site role.
Job description
In this role, you will have the opportunity to:
- Support the annual strategy process through situational analysis, strategic priority development, workshop preparation, leadership reviews, and concise, executive-ready materials that translate complex information into clear insights, choices, and recommendations.
- Partner with Finance and business leaders to connect market, portfolio, and strategic assumptions with financial plans by developing market models, opportunity assessments, financial analyses, investment requirements, growth expectations, and business cases.
- Translate strategic priorities into executable initiatives with clear owners, milestones, deliverables, and performance measures; establish Daily Management and recurring reviews to track progress, identify gaps, document decisions and actions, manage risks and dependencies, escalate issues, and ensure follow-through on countermeasures.
- Support strategic portfolio management and prioritization by consolidating product roadmaps, market priorities, investment needs, portfolio risks, and organic and inorganic growth opportunities; inform investment, resource-allocation, and product lifecycle decisions through market, customer, competitor, and technology analysis.
- Maintain strategy and portfolio dashboards, decision frameworks, initiative trackers, and standard work; lead defined analytical workstreams; assess adjacent markets, new business models, strategic partnerships, licensing opportunities, and potential acquisition targets; and apply Danaher Business System tools to strengthen strategy execution, portfolio governance, and decision-making.
Requirements
- Bachelor's degree in Life Sciences, Biomedical Engineering, Biotechnology, Business, Economics, Finance, or a related field
- 5+ years of relevant experience in life sciences strategy consulting, strategic portfolio management, business development, market intelligence, or a related analytical role
- Or 10+ years of relevant life sciences experience in lieu of a degree
- Strong strategic and analytical problem-solving skills
- Ability to structure ambiguous questions, synthesize complex information, and develop clear, fact-based recommendations for senior stakeholders
- Demonstrated experience in market research, competitive analysis, market sizing, financial analysis, and business-case development
- Strong project-management and cross-functional coordination capabilities
- Disciplined follow-through on actions and commitments
- Ability to work effectively in a global, matrixed organization
- Advanced proficiency in Microsoft PowerPoint and Excel
- Strong aptitude for learning and using relevant AI tools
- Excellent written and verbal communication skills
- Ability to travel approximately 15%, including occasional international travel
Benefits
- Health care program
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.